Anitua Eduardo, Alkhraisat Mohammad H
Clínica Eduardo Anitua, Vitoria, Spain.
BTI Biotechnology Institute, Vitoria, Spain.
Heliyon. 2019 Dec 12;5(12):e02965. doi: 10.1016/j.heliyon.2019.e02965. eCollection 2019 Dec.
To describe the outcomes of the adjuvant use of plasma rich in growth factors (PRGF) in the inferior alveolar nerve repositioning surgery.
A retrospective report of three cases was conducted in a single private dental clinic. The variables were the residual alveolar bone height, the surgical complications, the occurrence of neurosensory complications, the marginal bone stability and the implant survival. A descriptive statistical analysis was performed.
Three inferior alveolar repositioning were performed with the adjuvant use of PRGF. The residual alveolar bone height was 2.2 ± 0.14 mm. All patients underwent uneventful healing with no symptoms of neurosensory complications neither implant failure. The marginal bone loss was 0.1 ± 0.4 mm.
The preventative and adjuvant use of PRGF in inferior alveolar nerve repositioning need to be assessed in prospective studies with a larger sample size.
描述富含生长因子血浆（PRGF）在牙槽神经重新定位手术中辅助使用的效果。
在一家私立牙科诊所对3例病例进行回顾性报告。变量包括剩余牙槽骨高度、手术并发症、神经感觉并发症的发生情况、边缘骨稳定性和种植体存活率。进行了描述性统计分析。
在PRGF的辅助下进行了3次牙槽神经重新定位。剩余牙槽骨高度为2.2±0.14毫米。所有患者均顺利愈合，无神经感觉并发症症状，也无种植体失败情况。边缘骨丢失为0.1±0.4毫米。
需要在更大样本量的前瞻性研究中评估PRGF在牙槽神经重新定位中的预防性和辅助性使用。
